PCCI’s predictive model helps prevent adverse drug events

DALLAS – Parkland Center for Clinical Innovation (PCCI), which improves healthcare for vulnerable populations with advanced data science and clinical expertise, has developed a predictive model that in two years has helped prevent more than 2,000 adverse drug events (ADEs) for hospitalized patients, delivering a potential savings of over $17 million by reducing re-admissions and eliminating ADEs.

The program, Patients at Risk for Adverse Drug Events (PARADE), is a partnership between PCCI and Parkland Health & Hospital System. During the two years of implementation, PARADE has demonstrated positive results combating ADEs, a problem that impacts more than 450,000 patients nationwide and increases the risk for re-admissions, lengthens the stay of patients by two to three days and adds almost $4 billion in extra hospital costs annually. The most common drug classes associated with ADEs include anticoagulants, diabetes medications, and opioids.

PARADE screens all adult patients at the point of hospitalization and flags high risk individuals who can benefit from pharmacist intervention. To score a patient’s level of risk, PARADE captures a patient’s medical history, including medications and disease complexity, prior healthcare utilization, demographics and social determinants of health. It then provides results in real-time, with seamless integration into a patient’s electronic health record (EHR).

During its two years of implementation at Parkland, the PARADE program has screened more than 87,000 patients, with 8,731 high-risk patients identified. Of the high-risk patients, 16 percent received timely pharmacy intervention and more than 2,000 adverse drug events were prevented. For high-risk patients receiving a consult, the 30-day readmission rate was cut by 23.5 percent.

“Close collaboration with Parkland’s front-line pharmacy team from idea to implementation has been critical for the success of PARADE,” said Manjula Julka, MD, PCCI’s Vice President, Clinical Innovation. “PARADE has proven to improve quality of care by helping the pharmacy team to identify and intervene with high risk patients within 24 to 48 hours of admission. Upwards of 50 percent of ADEs are detectable and preventable and PARADE gives us a potent tool to help hospitals stay ahead of a difficult problem that causes longer stays and drives significant costs for hospitals.”

Kristin Alvarez, PharmD, BCPS, Associate Director Clinical Advancement/Best Practices for Parkland and Brett Moran, MD, Chief Medical Informatics Officer for Parkland, led implementation of PARADE at Parkland. Due to the model’s high accuracy and real-time user-friendly information, Parkland has adopted PARADE as a primary tool for pharmacist daily workflow for consult identification with demonstrated impact on preventing potential ADEs.

About Parkland Center for Clinical Innovation

Parkland Center for Clinical Innovation (PCCI) is an independent, not-for-profit, healthcare intelligence organization affiliated with Parkland Health & Hospital System. PCCI focuses on creating connected communities through data science and cutting-edge technologies like machine learning. PCCI combines extensive clinical expertise with advanced analytics and artificial intelligence to enable the delivery of patient-centric precision medicine at the point of care.



Dr. Steve Miff Awarded Social Innovator of the Year

Dr. Steve Miff Awarded Social Innovator of the Year

The Community Council of Dallas’ Annual Nonprofit and Community Leadership Awards Luncheon Will Honor Local Nonprofit Organizations and Leaders

Dallas, TX – The Community Council of Dallas, has awarded Dr. Steve Miff, the Parkland Center for Clinical Innovation’s (PCCI) President and CEO, with the 2017 Social Innovator of the Year Award. This year’s luncheon will be held on Thursday, November 2.

Ken Goodgames, CEO, Community Council of Dallas said, “Steve has a considerable gift to combine innovative technology approaches with a deep understanding of the social and health challenges we face in Dallas to identify solutions and resolve ongoing community challenges. I consider it a privilege to collaborate with him and his team. His work is game changing!”

Since it’s founding in 1940, the Community Council has identified services that are needed in the community, assessed how services could best be delivered to meet social issues, and mobilized and implemented action plans working in concert with its public sector resources. PCCI’s focus on leveraging artificial intelligence and cognitive computing to create connected communities complements the Community Council’s mission and vision for the community.

“I’m both honored and humbled by this great award and recognition.  It is truly a reflection of the work of the entire PCCI team, and the result of the collaboration with our colleagues at Parkland and across the Dallas community.” added Steve Miff. 

PCCI’s work is improving the health and lives of over 500,000 individuals at Parkland and across the Dallas community.  The Information Exchange Portal (IEP) is one of PCCI’s innovative programs focusing on addressing the health and social needs of a community. The program connects healthcare providers and community based organizations to coordinate the communication and care for individuals. With patients’ consent, providers use the portal to share relevant medical and social information with homeless shelters, food banks, and other nonprofits.

About PCCI

PCCI is an advanced, not-for-profit healthcare analytics R&D organization with a mission to create a world of connected communities where every health outcome is positive. We combine deep clinical expertise with advanced analytics and artificial intelligence to enable the delivery of precision medicine at the point of care. PCCI is a recipient of more than $50 million in grants directed at developing and deploying patient centric cutting edge technologies connecting communities, Parkland Health & Hospital System, and beyond.

Lindsey Nace, Marketing and Communications